RxDoctor Payments Data

April Turner, MD

Family Medicine · Jacksonville, FLNPI 1629043864

Payments from drug & device makers

$730in general payments, 2019–2025

Across 39 payments — averaging $18.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$217
  • Novartis$81
  • GSK$67
  • Corcept Therapeutics$39
  • Boehringer Ingelheim$39
  • Tolmar Pharmaceuticals, Inc.$37
  • plus $251 from 11 others

What the payments were for

  • Food & beverage$730100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$730 in reported general payments places this provider in the 55th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$17,601
Medicare patients
91
Services billed
231

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban101$126,417
InvokanaCanagliflozin54$41,315
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$28,929
XareltoRivaroxaban19$25,607
TresibaInsulin Degludec29$23,462
MyrbetriqMirabegron16$16,959
OzempicSemaglutide12$11,052
SymbicortBudesonide/Formoterol Fumarate18$7,319
Tresiba Flextouch U-100Insulin Degludec15$7,130
Albuterol Sulfate HfaAlbuterol Sulfate174$6,545
Rosuvastatin Calcium663$6,289
Fluticasone-SalmeterolFluticasone Propion/Salmeterol27$6,069
Novolog FlexpenInsulin Aspart17$4,510
NovologInsulin Aspart14$3,829
Wixela InhubFluticasone Propion/Salmeterol17$3,272

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$217$126,417101 claims
Johnson & JohnsonInvokana, Xarelto$21$66,92273 claims
Novo NordiskTresiba, Ozempic, Novolog$31$38,34355 claims
GSKTrelegy Ellipta$67$28,92923 claims
AstraZenecaSymbicort$25$7,31918 claims
AbbVieSynthroid$20$1,37412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →